New Sleep Apnea Pill AD109 Cuts Breathing Events 44%
A Phase 3 trial of AD109, a once-nightly sleep apnea pill, cut breathing events by 44% and may offer a CPAP alternative for millions.
New Sleep Apnea Pill AD109 Cuts Breathing Events 44% Read More »










